Genix Pharmaceuticals Corporation (GENPF)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -220.67 Thousand | -219.57 Thousand | -428.31 Thousand | -195.03 Thousand | -58.55 Thousand | 34.17 Thousand |
| Net Income | -4.39 Million | -1.07 Million | -1.65 Million | -718.66 Thousand | -164.7 Thousand | -25.2 Thousand |
| Depreciation & Amortization | 547.42 Thousand | 564.17 Thousand | 536.61 Thousand | 361.56 Thousand | 253.00 | 109.00 |
| Deferred income taxes | -1.09 Million | 28.48 Thousand | - | -748.67 Thousand | - | - |
| Stock-based compensation | 59.21 Thousand | 258.82 Thousand | 809.37 Thousand | 96.92 Thousand | - | - |
| Change in working capital | 56.24 Thousand | -5673.00 | -123.76 Thousand | 65.13 Thousand | 43.07 Thousand | 31.87 Thousand |
| Other non-cash items | 4.6 Million | 8609.00 | 1982.00 | 748.67 Thousand | 62.82 Thousand | 27.39 Thousand |
| Investing Cash Flow | - | -3339.00 | - | -8000.00 | 20 Thousand | -65.33 Thousand |
| Investments in PPE | - | -3339.00 | - | -8000.00 | - | - |
| Acquisitions | - | - | - | -8000.00 | - | -65.33 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -3339.00 | - | 8000.00 | 20 Thousand | 1.00 |
| Financing Cash Flow | 223.03 Thousand | 93.37 Thousand | -129.48 Thousand | 868.29 Thousand | 20 Thousand | - |
| Debt repayment | -281.87 Thousand | -20.75 Thousand | -14 Thousand | -5400.00 | -20 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 986.19 Thousand | - | - |
| Other Financing Activities | 504.91 Thousand | 114.12 Thousand | -115.48 Thousand | 868.29 Thousand | 20 Thousand | - |
| Accounts receivables | 15.09 Thousand | -11.63 Thousand | 3037.00 | -3979.00 | 111.96 Thousand | -48.98 Thousand |
| Accounts payables | 29.11 Thousand | 175.98 Thousand | -93.52 Thousand | 75.36 Thousand | -42.6 Thousand | 41.9 Thousand |
| Inventory | 12.2 Thousand | -166.48 Thousand | -4835.00 | 3979.00 | -31.12 Thousand | 64.7 Thousand |
| Other working capital | -173.00 | -3543.00 | -28.44 Thousand | -10.22 Thousand | 4836.00 | -74.73 Thousand |
| Cash at beginning of period | 9267.00 | 138.81 Thousand | 696.6 Thousand | 31.34 Thousand | 69.89 Thousand | 101.05 Thousand |
| Cash at end of period | 11.63 Thousand | 9267.00 | 138.81 Thousand | 696.6 Thousand | 31.34 Thousand | 69.89 Thousand |
| Capital Expenditure | - | -3339.00 | - | -8000.00 | - | - |
| Effect of forex changes on cash | - | - | - | - | -20 Thousand | - |
| Net cash flow / Change in cash | 2364.00 | -129.54 Thousand | -557.79 Thousand | 665.26 Thousand | -38.55 Thousand | -31.16 Thousand |
| Free Cash Flow | -220.67 Thousand | -222.91 Thousand | -428.31 Thousand | -203.03 Thousand | -58.55 Thousand | 34.17 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -82.17 Thousand | -85.94 Thousand | -59.05 Thousand | -3.77 Million | -4.39 Million | -164.09 Thousand |
| Depreciation & Amortization | 283.00 | 283.00 | 283.00 | 135.92 Thousand | 547.42 Thousand | 135.92 Thousand |
| Deferred income taxes | - | - | - | -332.16 Thousand | -1.09 Million | - |
| Stock-based compensation | - | - | - | 59.21 Thousand | 59.21 Thousand | - |
| Change in working capital | 3037.00 | -5715.00 | 874.00 | 17.77 Thousand | 56.24 Thousand | -27.15 Thousand |
| Other non-cash items | 31.81 Thousand | 38.42 Thousand | 15.33 Thousand | 3.82 Million | 4.6 Million | 2501.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 46.61 Thousand | 58.74 Thousand | 40.22 Thousand | 67.94 Thousand | 223.03 Thousand | 16.71 Thousand |
| Debt repayment | -46.61 Thousand | -58.74 Thousand | -40.22 Thousand | -62.94 Thousand | -281.87 Thousand | -218.92 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 46.61 Thousand | 58.74 Thousand | 40.22 Thousand | 130.89 Thousand | 504.91 Thousand | 235.64 Thousand |
| Accounts receivables | -1206.00 | -720.00 | -1582.00 | 11.6 Thousand | 15.09 Thousand | 1714.00 |
| Accounts payables | - | -5013.00 | 26.73 Thousand | -15.83 Thousand | 29.11 Thousand | -37.19 Thousand |
| Inventory | 357.00 | 748.00 | -1902.00 | 3124.00 | 12.2 Thousand | 433.00 |
| Other working capital | 15.83 Thousand | -730.00 | -22.37 Thousand | 18.89 Thousand | -173.00 | 7885.00 |
| Cash at beginning of period | 9546.00 | 9297.00 | 11.63 Thousand | 4237.00 | 9267.00 | 40.35 Thousand |
| Cash at end of period | 10.23 Thousand | 9546.00 | 9297.00 | 11.63 Thousand | 11.63 Thousand | 4237.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 686.00 | 249.00 | -2334.00 | 7394.00 | 2364.00 | -36.12 Thousand |
| Free Cash Flow | -45.93 Thousand | -58.49 Thousand | -42.56 Thousand | -60.55 Thousand | -220.67 Thousand | -52.83 Thousand |
BNL
IOC
VLOWY
PHOENIXTN
002849
1I1